This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Disorders of lacrimal system and orbit in diseases classified elsewhere
H7_LACRIMALORBITINOTH
eye disease: A non-neoplastic or neoplastic disorder that affects the eye. Representative examples include conjunctivitis, glaucoma, cataract, conjunctival squamous cell carcinoma, uveal melanoma, and retinoblastoma. [NCIt:C26767]
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
958 |
4. Check minimum number of eventsNone |
958 |
5. Include endpointsNone |
958 |
6. Filter based on genotype QC (FinnGen only) |
919 |
Control definitions (FinnGen only)
- Control exclude
- H7_LIDLACRIMALORBIT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Disorders of lacrimal system and orbit in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Disorders of orbit
- Disorders of eyelid, lacrimal system and orbit
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 919 | 756 | 163 |
| Unadjusted period prevalence (%) | 0.23 | 0.27 | 0.07 |
| Median age at first event (years) | 52.60 | 52.25 | 54.22 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 958
- Matched controls
- 9580
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
104
Kela drug reimbursment
Thyroid insufficiency
14.7
307.7
376
402
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
91.5
307.7
500
113
H03AA01
ATC
levothyroxine sodium; systemic
20.1
307.7
786
1776
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
43.3
307.7
256
80
BAA60
NOMESCO Finland
Total thyroidectomy
44.4
307.7
334
114
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
+∞
307.7
834
*
H03BB01
ATC
carbimazole; oral
176.8
307.7
753
195
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
445.6
307.7
818
124
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
53.7
259.6
150
33
H06.2
ICD-10 Finland
Dysthyroid exophthalmos
+∞
249.2
228
*
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
40.8
236.2
146
42
H062, E050,
ICD-10 Finland
+∞
235.4
216
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
7.8
182.2
748
2994
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
76.3
167.0
90
13
H53.2
ICD-10 Finland
Diplopia
14.5
161.3
155
126
H50.2
ICD-10 Finland
Vertical strabismus
53.5
160.1
92
19
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
5.0
132.3
595
2364
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
194.4
131.2
134
8
C07AA05
ATC
propranolol; systemic
4.6
114.6
422
1408
H04.10
ICD-10 Finland
Dry eye syndrome
6.9
113.5
202
359
H02.3
ICD-10 Finland
Blepharochalasis
35.9
110.6
70
21
XCK00
NOMESCO Finland
Perimetry
7.9
107.1
162
241
H05.2
ICD-10 Finland
Exophthalmic conditions
+∞
106.3
100
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
5.8
102.9
221
469
T85
ICPC
Hyperthyroidism/thyrotoxicosis
22.9
70.6
52
24
H02AB06
ATC
prednisolone; systemic
3.3
69.2
613
3346
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.6
64.9
278
976
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
15.0
64.4
58
41
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.5
63.1
133
272
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.6
61.5
253
862
E03.89
ICD-10 Finland
Other specified hypothyroidism
6.1
58.6
109
198
ZX120
NOMESCO Finland
Intravenous
4.2
57.8
176
485
H50.0
ICD-10 Finland
Convergent concomitant strabismus
20.4
55.8
43
22
H02.4
ICD-10 Finland
Ptosis of eyelid
20.9
55.0
42
21
T86
ICPC
Hypothyroidism/myxoedema
5.6
54.1
110
217
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
10.4
53.9
61
62
CAC30
NOMESCO Finland
Decompression of orbit to sinuses
+∞
53.6
51
*
CA1AD
NOMESCO Finland
Orbita CT
175.6
48.3
50
*
ZXA10
NOMESCO Finland
Bilateral
3.1
46.7
249
978
XCD10
NOMESCO Finland
Electrophysiological examination of eye
8.1
44.2
61
80
H50.6
ICD-10 Finland
Mechanical strabismus
+∞
44.1
42
*
CEC00
NOMESCO Finland
Recession of extraocular muscle
73.5
43.4
49
7
E06.2
ICD-10 Finland
Chronic thyroiditis with transient thyrotoxicosis
+∞
38.8
37
*
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
8.8
38.5
49
58
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
11.6
38.2
40
36
E03
ICD-10 Finland
Other hypothyroidism
3.9
38.1
125
359
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
36.1
267
1228
CAC44
NOMESCO Finland
Combined decompression of orbit
359.9
35.2
35
*
H50.8
ICD-10 Finland
Other specified strabismus
128.2
34.9
37
*
A02BC02
ATC
pantoprazole; systemic
2.6
34.2
733
5348
L04AX03
ATC
methotrexate; systemic
3.1
32.5
151
540
C07AB07
ATC
bisoprolol; oral
2.2
32.2
493
3088
WF099
NOMESCO Finland
Other radiotherapy
36.9
30.8
39
11
CAC20
NOMESCO Finland
Lateral decompression of orbit
+∞
30.4
29
*
H02.5
ICD-10 Finland
Other disorders affecting eyelid function
311.8
30.0
30
*
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
4.6
29.0
71
163
XCK10
NOMESCO Finland
Photography of fundus of eye
3.2
27.7
118
399
H02AB07
ATC
prednisone; oral
2.6
27.7
185
800
CBK00
NOMESCO Finland
Myotomy or resection of tarsal muscle or levator muscle of eyelid for correction of retraction
+∞
27.2
26
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
4.9
26.5
60
129
CS494
NOMESCO Finland
Other visual field testing
5.6
25.7
50
94
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
40.0
25.0
31
8
H01.0
ICD-10 Finland
Blepharitis
3.8
24.5
78
218
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
24.4
286
1573
A11CC03
ATC
alfacalcidol; systemic
6.3
23.4
40
66
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.9
22.8
117
439
CEC60
NOMESCO Finland
Transposition of extraocular muscle with adjustable suture
123.0
22.7
24
*
E05.1
ICD-10 Finland
Thyrotoxicosis with toxic single thyroid nodule
36.0
22.1
28
8
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
21.9
403
2590
L04AA06
ATC
mycophenolic acid; systemic
7.3
21.7
32
45
Z3231
NOMESCO Finland
Registered nurse
2.1
21.7
290
1665
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
21.7
383
2427
H57.1
ICD-10 Finland
Ocular pain
4.3
21.6
58
143
N05CF01
ATC
zopiclone; oral
2.0
20.9
345
2130
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
4.3
20.8
55
134
CEW99
NOMESCO Finland
Other operation on extraocular muscle
78.6
20.8
23
*
E05.5
ICD-10 Finland
Thyroid crisis or storm
214.5
20.7
21
*
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
4.8
20.3
46
99
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
20.2
435
2924
2AB04, ,
NOMESCO Finland
27.7
20.1
27
10
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.2
20.0
85
286
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
36.6
19.9
25
7
CEC90
NOMESCO Finland
Total transposition of extraocular muscle or muscles
+∞
19.9
19
*
CA1BM
NOMESCO Finland
Eye and orbita MRI examination with 3 Tesla magnet
+∞
19.9
19
*
WF002
NOMESCO Finland
Radical radiotherapy
3.8
19.4
60
164
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
16.0
19.4
31
20
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.2
19.3
81
270
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.9
19.3
326
2017
WX402
NOMESCO Finland
General anaesthesia
2.1
19.2
233
1283
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
18.7
19.2
29
16
CBB11
NOMESCO Finland
Resection of lax skin in upper eyelid
+∞
18.8
18
*
CBB21
NOMESCO Finland
Correction of lax skin and resection of herniated fat in upper eyelid
+∞
18.8
18
*
CBB10
NOMESCO Finland
Excision of redundant skin of eyelid
96.9
17.6
19
*
E05.89
ICD-10 Finland
Other thyrotoxicosis
42.8
17.3
21
5
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
5.4
17.1
34
65
CBB20
NOMESCO Finland
Correction of lax skin of eyelid and resection of herniated fat
172.9
16.5
17
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
12.4
16.4
29
24
S01GX01
ATC
cromoglicic acid; ophthalmic
1.9
15.7
228
1327
H02.0
ICD-10 Finland
Entropion and trichiasis of eyelid
86.5
15.6
17
*
H02AB09
ATC
hydrocortisone; systemic
4.6
15.5
37
83
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.1
15.0
164
863
Z3229
NOMESCO Finland
Other healthcare associate professional
2.6
14.4
85
342
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
22.7
14.3
20
9
S01KA02
ATC
hypromellose; ophthalmic
5.0
14.1
30
61
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
10.7
13.8
26
25
H40.0
ICD-10 Finland
Glaucoma suspect
2.5
13.3
85
355
WX002
NOMESCO Finland
Sedation and analgesia
1.9
13.0
188
1086
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
15.7
12.6
20
13
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
70.8
12.6
14
*
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
+∞
12.5
12
*
CE2W4
NOMESCO Finland
Eye movement mapping
38.1
12.2
15
*
106
Kela drug reimbursment
Hypoparathyroidism
16.1
12.2
19
12
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
13.6
12.0
20
15
H02.8
ICD-10 Finland
Other specified disorders of eyelid
47.3
11.9
14
*
CA1BD
NOMESCO Finland
Extensive orbita CT
65.8
11.6
13
*
1XC02, ,
NOMESCO Finland
10.2
11.5
22
22
F29
ICPC
Eye symptom/complaint other
2.2
11.5
98
465
CBK99
NOMESCO Finland
Other operation for retraction of eyelid
+∞
11.5
11
*
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
9.8
11.3
22
23
XCH00
NOMESCO Finland
Eye pressure measurement
3.1
11.2
48
162
H03BA02
ATC
propylthiouracil; oral
25.4
11.2
15
6
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
3.8
11.1
33
88
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
10.6
212
1345
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
10.2
10.5
20
20
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
10.7
10.3
19
18
N07BA03
ATC
varenicline; oral
2.6
10.2
58
229
Z2221
NOMESCO Finland
Medical doctor
1.6
10.1
268
1831
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
14.8
10.0
16
11
CD2S4
NOMESCO Finland
Photography of eye
14.8
10.0
16
11
S01XA18
ATC
ciclosporin; ophthalmic
26.3
9.8
13
5
H50.52
ICD-10 Finland
Exophoria
5.0
9.8
21
43
ZXE00
NOMESCO Finland
One hour or less
1.6
9.8
362
2675
H02.1
ICD-10 Finland
Ectropion of eyelid
101.0
9.4
10
*
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
30.3
9.4
12
*
H50.1
ICD-10 Finland
Divergent concomitant strabismus
13.8
9.2
15
11
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.3
9.1
71
325
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
10.2
9.0
17
17
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.2
9.0
36
117
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
3.6
8.8
29
83
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.0
8.8
104
558
CB9S4
NOMESCO Finland
Photography of eyelids and eyebrows
50.5
8.7
10
*
ZXA00
NOMESCO Finland
Right side
1.6
8.7
231
1572
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
27.8
8.5
11
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
4.0
8.4
23
58
CBJ40
NOMESCO Finland
Resection of levator muscle of eyelid
+∞
8.3
8
*
E05.4
ICD-10 Finland
Thyrotoxicosis factitia
33.6
8.1
10
*
A11CC02
ATC
dihydrotachysterol; oral
11.8
8.1
14
12
ZXC95
NOMESCO Finland
Use of surgical navigator
4.3
8.0
20
47
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.1
7.9
73
358
WX892
NOMESCO Finland
Monitored bed care
2.2
7.8
64
300
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.6
7.8
220
1516
H02.9
ICD-10 Finland
Disorder of eyelid, unspecified
45.3
7.7
9
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
7.7
132
799
H05.0
ICD-10 Finland
Acute inflammation of orbit
80.7
7.4
8
*
WX140
NOMESCO Finland
Parabulbar anesthesy
2.6
7.3
42
167
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
7.3
658
5707
S01EE01
ATC
latanoprost; ophthalmic
2.3
7.3
52
229
CAB00
NOMESCO Finland
Anterior orbitotomy with excision of lesion
+∞
7.3
7
*
H05.1
ICD-10 Finland
Chronic inflammatory disorders of orbit
+∞
7.3
7
*
CBD99
NOMESCO Finland
Other plastic reconstruction of eyelid
+∞
7.3
7
*
H02.2
ICD-10 Finland
Lagophthalmos
+∞
7.3
7
*
S01ED01
ATC
timolol; ophthalmic
3.1
7.2
29
95
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
20.2
7.1
10
5
2420A
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic diffuse goitre
20.2
7.1
10
5
ZX050
NOMESCO Finland
Stereotactic radiotherapy
8.0
7.1
15
19
R4110
NOMESCO Finland
Physiotherapy
1.5
7.1
242
1736
H11.1
ICD-10 Finland
Conjunctival degenerations and deposits
10.1
7.0
13
13
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
7.0
381
2997
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.1
6.9
67
335
K90.0
ICD-10 Finland
Coeliac disease
2.8
6.9
34
125
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
2.2
6.9
59
281
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
7.2
6.7
15
21
Z71.8
ICD-10 Finland
Other specified counselling
1.5
6.7
283
2116
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.4
6.7
45
194
R03BB04
ATC
tiotropium bromide; inhalant
1.9
6.6
81
441
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
3.4
6.6
23
69
R53
ICD-10 Finland
Malaise and fatigue
1.5
6.5
208
1467
A02BC05
ATC
esomeprazole; systemic
1.4
6.5
369
2915
E06.3
ICD-10 Finland
Autoimmune thyroiditis
6.2
6.5
16
26
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
3.2
6.5
25
80
H02AB04
ATC
methylprednisolone; systemic
1.7
6.4
129
813
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
6.4
120
742
ZXD20
NOMESCO Finland
Day surgery
1.7
6.4
121
750
E50.0
ICD-10 Finland
Vitamin A deficiency with conjunctival xerosis
70.3
6.4
7
*
CBG00
NOMESCO Finland
Epilation of cilia by electrolysis
70.3
6.4
7
*
H01CB02
ATC
octreotide; parenteral
14.4
6.4
10
7
E83.51
ICD-10 Finland
Hypocalcemia
6.6
6.3
15
23
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.2
6.3
24
76
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
6.3
325
2520
CBN99
NOMESCO Finland
Other operation on eyelid for malposition
+∞
6.3
6
*
G73.0*E05.9
ICD-10 Finland
Myasthenic syndromes in thyrotoxicosis [hyperthyroidism]
+∞
6.3
6
*
H05.9
ICD-10 Finland
Disorder of orbit, unspecified
+∞
6.3
6
*
H060, E050,
ICD-10 Finland
+∞
6.3
6
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
6.2
105
631
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
3.6
6.2
20
57
107
Kela drug reimbursment
Pernicious anaemia
3.6
6.2
20
57
N02BE01
ATC
paracetamol; systemic, rectal
1.6
6.2
831
7667
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.2
363
2881
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
6.2
79
437
BAA25
NOMESCO Finland
Bilateral partial excision of thyroid gland
12.6
6.1
10
8
F01
ICPC
Eye pain
2.7
6.0
31
117
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
2.0
6.0
61
311
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
491
216
45.58
307.65
5.1
1.7
6.24
4.48
iu/l
1.31
347
77
480
538
16.88
307.65
7.9
3.3
4.62
4.54
pmol/l
0.53
455
477
930
6643
14.68
73.01
14.8
4.2
15.81
14.66
pmol/l
34.67
897
6096
220
664
4.00
64.14
1.4
1.2
221.99
157.73
iu/ml
1.35
101
269
607
3791
2.64
45.05
7.1
6.1
1.21
1.22
mmol/l
1.56
522
3214
551
3433
2.42
38.83
6.0
5.2
1.21
1.22
mmol/l
1.29
522
3111
934
7727
9.33
37.59
16.2
4.9
1.63
2.04
mu/l
1.83
903
7118
667
4640
2.44
34.98
9.0
8.6
3.83
3.97
e9/l
1.10
582
4066
162
595
3.07
33.31
2.8
3.4
51.26
80.94
ng/l
11.59
144
533
433
2641
2.17
29.42
3.2
3.4
2.33
2.36
mmol/l
4.65
388
2325
523
3465
2.12
28.27
2.7
2.3
77.20
77.72
nmol/l
0.16
481
3123
780
6172
2.42
25.29
8.5
6.9
76.79
76.89
u/l
0.02
756
5797
547
3824
2.00
23.96
5.7
5.5
28.60
28.67
%
0.05
517
3577
538
3775
1.97
22.91
5.7
5.3
56.17
56.79
%
0.61
508
3525
159
728
2.42
20.69
2.4
2.0
367.24
376.09
nmol/l
0.24
147
672
735
6000
1.97
17.19
4.7
3.9
11.64
11.85
mm/h
0.16
695
5549
573
4438
1.72
14.68
4.3
4.1
6.41
6.59
mmol/l
1.26
538
4125
37
89
4.28
14.24
3.6
5.0
46.74
59.61
u/ml
—
10
26
916
8335
3.26
13.90
16.4
13.5
3.92
3.94
mmol/l
2.46
899
8084
914
8309
3.18
13.85
16.2
13.4
139.81
139.72
mmol/l
0.51
899
8074
420
3054
1.67
13.11
2.1
1.9
99.83
96.92
pmol/l
0.59
210
1517
893
8115
2.48
11.84
13.7
12.0
21.32
21.22
mg/l
0.03
708
6279
252
1636
1.73
11.77
1.5
1.4
2.15
2.33
g/l
0.93
137
996
429
3207
1.61
11.54
4.1
4.4
35.88
35.92
g/l
0.05
400
3011
838
7448
2.00
11.48
6.0
5.3
38.94
39.24
mmol/mol
0.47
792
6917
282
1910
1.68
11.18
1.4
1.2
1.28
1.87
u/ml
0.53
71
491
24
51
4.80
10.75
1.1
1.1
1.13
0.27
nmol/l
—
7
8
872
7905
2.15
10.63
4.9
4.3
5.85
5.85
mmol/l
0.02
828
7235
49
181
2.80
9.80
1.2
1.2
60.77
40.89
u/ml
—
6
19
927
8701
3.02
9.19
13.8
9.6
23.95
25.08
u/l
1.78
912
8401
205
1366
1.64
8.36
2.9
2.8
2.43
2.45
mmol/l
1.74
175
1194
198
1308
1.65
8.35
4.1
3.3
222.03
340.32
ng/l
0.30
151
924
640
5458
1.52
8.29
3.4
2.9
36.47
43.87
u/l
2.69
613
5109
848
7749
1.82
8.09
13.6
11.1
84.09
82.87
ml/min/173m2
1.01
730
6336
795
7139
1.67
8.06
20.7
14.6
14.71
14.87
%
0.36
788
7017
276
1993
1.54
7.94
2.9
2.8
0.28
0.41
e6/l
0.91
197
1475
175
1162
1.62
7.16
3.2
3.0
0.82
0.82
mmol/l
0.11
160
1095
164
1103
1.59
6.32
2.8
2.7
4.28
3.48
e6/l
0.27
83
555
333
2598
1.43
6.23
3.2
2.9
—
—
—
0
0
250
1861
1.46
5.97
2.5
2.1
2.58
3.03
mg/l
3.21
224
1574
255
1908
1.46
5.92
4.2
3.4
92.72
95.74
%
1.13
250
1852
54
265
2.10
5.90
1.8
2.0
—
—
—
0
0
248
1875
1.44
5.38
2.2
2.1
—
—
—
0
0
482
4086
1.36
5.23
5.5
5.7
11.00
10.71
umol/l
0.21
459
3886
169
1194
1.50
5.17
2.6
2.5
1.84
1.23
e6/l
0.47
88
642
280
2178
1.40
5.15
3.1
2.9
35.57
55.00
e6/l
0.51
200
1637
940
9081
2.87
5.11
25.4
18.2
262.25
258.86
e9/l
0.95
918
8861
82
488
1.74
5.06
2.7
2.7
146.93
157.71
ng/l
0.12
73
449
128
856
1.57
5.03
2.0
2.4
6.16
7.36
umol/l
0.68
105
737
108
695
1.62
4.98
2.2
2.2
28.57
39.71
u/l
2.30
92
587
940
9088
2.83
4.96
25.3
18.2
4.51
4.46
e12/l
2.41
917
8843
939
9074
2.76
4.96
25.4
18.2
40.40
39.87
%
2.30
896
8546
940
9091
2.81
4.90
25.5
18.3
135.18
134.04
g/l
2.15
934
8963
136
930
1.54
4.84
4.5
4.7
1.06
1.03
mmol/l
0.45
120
859
435
3661
1.34
4.81
3.5
2.7
90.56
101.45
ug/l
0.82
404
3403
36
168
2.19
4.52
2.3
2.1
4.80
5.08
mmol/24h
0.27
30
147
46
238
1.98
4.42
1.5
1.5
0.23
0.06
iu/ml
—
8
42
325
2648
1.34
4.35
3.2
3.0
27.08
29.71
u/l
2.09
306
2528
75
455
1.70
4.35
1.3
1.3
27.64
31.13
iu/l
0.42
61
397
195
1464
1.42
4.32
1.3
1.3
7.44
11.82
u/ml
0.45
59
598
10
16
6.30
4.30
1.6
1.4
0.51
0.40
ug/l
—
5
11
383
3232
1.31
3.92
11.3
11.7
1.21
1.19
inr
0.16
104
939
198
1516
1.39
3.89
1.3
1.3
22.09
30.93
iu/ml
0.77
56
511
57
332
1.76
3.84
2.1
2.2
43.09
40.53
u/l
0.41
51
298
9
15
6.05
3.82
1.0
1.0
—
—
—
0
0
220
1731
1.35
3.63
1.4
1.5
20.33
21.42
nmol/l
0.58
192
1458
595
5356
1.29
3.59
3.1
3.1
—
—
—
0
0
40
213
1.92
3.59
1.2
1.8
38.39
38.60
g/l
0.09
34
194
172
1305
1.39
3.55
1.6
1.7
1084.34
1216.47
nmol/l
1.25
125
966
194
1504
1.36
3.51
2.4
2.3
7.15
7.29
e6/l
0.04
163
1347
275
2254
1.31
3.39
2.2
2.0
158.58
193.50
u/l
0.36
251
2131
430
3743
1.27
3.29
2.5
2.4
—
—
—
0
0
445
3891
1.27
3.28
4.9
4.6
0.00
0.00
estimate
0.50
86
728
449
3934
1.27
3.24
3.4
3.4
0.00
0.01
estimate
0.80
83
703
15
55
2.75
3.16
1.6
1.9
—
—
—
0
0
41
231
1.81
3.12
1.1
1.9
0.83
0.83
g/l
0.00
35
211
263
2165
1.30
3.11
1.7
1.6
1.32
1.36
mmol/l
0.37
226
1823
442
3879
1.26
3.10
3.4
3.4
0.00
0.00
estimate
0.75
88
771
134
1003
1.39
3.00
2.0
2.1
111.25
112.81
ug/g
0.01
108
790
90
627
1.48
2.97
3.2
3.3
1.22
1.23
mmol/l
1.34
85
530
46
276
1.70
2.85
1.5
1.7
—
—
—
0
0
273
2291
1.27
2.73
2.8
3.0
6.99
7.18
mmol/l
0.28
233
1946
42
249
1.72
2.73
1.2
1.9
9.74
10.24
g/l
0.45
36
229
75
516
1.49
2.65
1.4
1.8
—
—
—
0
0
17
74
2.32
2.59
1.5
1.2
0.54
1.39
u/ml
—
9
38
20
94
2.15
2.56
1.2
1.4
—
—
—
0
0
5
7
7.17
2.55
2.0
2.0
—
—
—
0
0
18
81
2.25
2.55
1.2
1.2
—
—
—
0
0
42
255
1.68
2.52
1.2
1.9
3.02
2.94
g/l
0.23
36
236
24
122
1.99
2.52
1.0
1.0
2.23
2.00
u/ml
—
7
50
36
212
1.73
2.42
2.6
2.0
171.10
247.97
ug/l
0.51
31
196
25
132
1.92
2.37
1.7
1.6
—
—
—
0
0
38
229
1.69
2.36
1.1
1.1
—
—
—
0
0
58
389
1.52
2.34
1.4
1.6
—
—
—
0
0
38
230
1.68
2.33
1.1
1.1
—
—
—
0
0
142
1119
1.32
2.30
1.8
1.8
—
—
—
0
0
40
247
1.65
2.28
1.5
1.6
0.23
0.23
g/l
0.23
35
236
131
1030
1.31
2.16
2.5
2.2
2.43
2.39
g/l
0.31
121
952
62
432
1.47
2.11
1.0
1.0
—
—
—
0
0
8
25
3.22
2.09
1.3
2.1
38.25
55.24
ug/l
—
8
25
23
124
1.88
2.08
1.0
1.0
0.75
1.44
u/ml
0.39
11
59
33
199
1.68
2.07
1.4
3.4
35.02
40.79
mg/l
0.41
24
164
42
270
1.58
2.06
1.2
1.8
4.23
3.60
g/l
0.47
36
251
42
270
1.58
2.06
1.2
1.8
7.65
7.42
g/l
0.39
36
251
42
270
1.58
2.06
1.2
1.8
—
—
—
0
0
79
579
1.40
2.05
1.4
2.7
66.27
67.29
g/l
0.59
69
531
100
762
1.35
2.05
3.1
4.1
229.68
256.49
u/l
0.78
92
726
280
2425
1.22
2.04
2.7
2.3
54.19
57.86
u/l
0.70
264
2245
40
257
1.58
1.98
1.5
1.6
1.16
1.19
g/l
0.18
35
243
14
64
2.21
1.95
1.1
1.2
—
—
—
0
0
14
64
2.21
1.95
1.1
1.2
—
—
—
0
0
212
1793
1.23
1.93
2.0
1.7
0.88
1.03
mg/l
0.48
155
1365
23
128
1.82
1.91
1.2
1.4
—
—
—
0
0
23
128
1.82
1.91
1.2
1.4
—
—
—
0
0
14
65
2.17
1.88
1.1
1.2
—
—
—
0
0
14
65
2.17
1.88
1.1
1.2
—
—
—
0
0
14
65
2.17
1.88
1.1
1.2
—
—
—
0
0
98
756
1.33
1.87
7.3
6.9
1.21
1.31
mmol/l
0.12
76
618
37
238
1.58
1.84
1.3
1.2
—
—
—
0
0
32
199
1.63
1.82
1.4
3.4
29.77
44.34
mg/l
0.47
23
164
183
1534
1.24
1.81
1.5
1.5
—
—
—
0
0
855
8278
1.31
1.80
4.9
4.7
2.88
2.87
mmol/l
0.15
795
7657
22
124
1.79
1.77
1.2
1.2
3.00
3.81
u/ml
0.13
11
36
841
8131
1.28
1.75
4.3
4.3
4.81
4.83
mmol/l
0.22
787
7576
17
304
0.55
1.67
4.8
3.5
67.28
48.93
%
2.40
17
299
96
753
1.31
1.65
1.7
1.7
—
—
—
0
0
42
287
1.48
1.62
1.6
1.7
1.40
1.44
g/l
0.14
31
249
139
1148
1.25
1.58
2.6
2.2
13.80
13.23
umol/l
0.43
130
1066
26
160
1.64
1.57
2.7
3.5
59.58
58.63
%
0.12
26
160
242
2118
1.19
1.55
2.9
3.2
316.83
336.36
mg/l
0.02
140
1293
25
154
1.64
1.51
2.7
3.4
4.57
4.19
e9/l
0.26
25
154
26
162
1.62
1.50
1.3
1.2
16.51
12.63
u/l
0.49
21
128
96
765
1.28
1.48
1.9
1.7
—
—
—
0
0
117
958
1.25
1.45
2.7
2.2
22.68
22.74
%
0.02
94
817
14
73
1.93
1.44
1.6
1.5
—
—
—
0
0
9
40
2.26
1.40
1.0
1.2
—
—
—
0
0
252
2233
1.17
1.39
3.5
3.7
5.84
7.36
mg/mmol
0.39
136
1351
59
446
1.34
1.34
1.2
1.4
—
—
—
0
0
9
43
2.10
1.30
1.0
1.0
—
—
—
0
0
833
8096
1.22
1.30
4.3
4.2
1.52
1.54
mmol/l
0.58
774
7497
13
69
1.90
1.29
1.1
1.2
—
—
—
0
0
10
48
2.09
1.28
1.1
1.1
—
—
—
0
0
15
84
1.80
1.27
1.6
1.5
—
—
—
0
0
32
219
1.48
1.27
1.4
1.4
257.53
302.63
ug/g
0.57
19
126
8
35
2.30
1.27
1.0
1.1
—
—
—
0
0
61
469
1.32
1.25
1.5
1.6
—
—
—
0
0
73
576
1.29
1.24
2.7
2.8
0.69
0.75
ug/l
0.29
46
353
21
131
1.62
1.24
1.6
1.6
—
—
—
0
0
5
19
2.64
1.21
1.0
1.2
—
—
—
0
0
20
124
1.63
1.21
1.3
1.2
2.73
5.28
u/ml
0.56
15
47
24
156
1.55
1.21
1.0
1.1
0.67
2.39
u/ml
1.29
12
81
53
403
1.33
1.18
1.3
1.6
—
—
—
0
0
19
297
0.63
1.18
1.4
1.9
—
—
—
0
0
5
20
2.51
1.15
1.2
1.1
47.24
34.52
u/ml
—
5
20
217
1929
1.16
1.14
2.4
2.9
964.71
991.27
ng/l
0.04
182
1601
27
183
1.49
1.14
3.2
2.6
—
—
—
0
0
17
103
1.66
1.13
2.1
2.8
—
2607.00
—
0
11
5
21
2.39
1.09
2.6
1.3
—
—
—
0
0
9
166
0.54
1.08
1.2
1.6
—
—
—
0
0
5
22
2.28
1.03
1.0
1.2
—
—
—
0
0
17
106
1.61
1.03
1.2
2.2
4.84
5.51
umol/l
0.17
11
74
303
2780
1.13
1.01
2.8
3.2
23.39
46.46
ng/l
0.91
163
1774
9
49
1.84
0.98
1.1
1.4
—
18.00
—
0
9
74
605
1.24
0.98
2.9
3.3
2.38
2.01
mmol/l
0.52
49
507
19
124
1.54
0.97
1.1
1.1
—
—
—
0
0
9
50
1.81
0.96
5.3
3.1
76.22
93.88
nmol/l
—
9
50
31
225
1.39
0.95
2.2
1.6
—
—
—
0
0
204
1831
1.15
0.95
1.3
1.4
—
—
—
0
0
7
37
1.90
0.94
1.1
1.1
1540.14
1684.24
miu/ml
—
7
37
40
304
1.33
0.93
3.0
3.2
24.87
24.04
mmol/l
1.26
40
298
38
291
1.32
0.86
1.7
1.9
—
—
—
0
0
12
191
0.62
0.85
1.3
1.5
—
—
—
0
0
36
275
1.32
0.83
1.1
1.3
198.32
228.55
miu/ml
0.20
19
131
28
206
1.37
0.82
1.1
1.3
—
—
—
0
0
8
47
1.71
0.80
1.1
1.1
—
—
—
0
0
24
173
1.40
0.79
2.0
1.7
2657.00
14542.14
e6/l
2.18
19
132
11
66
1.67
0.79
2.1
3.5
—
—
—
0
0
13
82
1.59
0.78
2.4
2.2
—
—
—
0
0
27
200
1.36
0.77
5.8
2.2
182.56
178.81
%
0.08
27
194
6
34
1.77
0.76
1.5
1.7
—
—
—
0
0
6
34
1.77
0.76
1.5
1.7
—
—
—
0
0
72
608
1.20
0.74
2.9
3.3
5.64
5.84
kpa
1.00
63
592
19
133
1.44
0.74
1.2
1.3
331.00
111.77
u/ml
—
6
28
9
55
1.64
0.73
1.6
1.4
—
—
—
0
0
67
790
0.84
0.71
1.7
1.6
—
—
—
0
0
34
265
1.29
0.70
1.6
1.8
—
—
—
0
0
17
118
1.45
0.69
2.1
1.6
—
—
—
0
0
17
118
1.45
0.69
2.1
1.6
—
—
—
0
0
51
616
0.82
0.69
2.4
2.3
67.72
69.04
ml/min/173m2
0.10
25
241
5
27
1.86
0.68
3.2
5.2
—
—
—
0
0
211
1941
1.11
0.67
2.3
2.4
6224.62
5543.48
umol/l
0.07
191
1711
15
103
1.46
0.65
1.1
1.2
—
—
—
0
0
31
244
1.28
0.62
1.4
1.5
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
8
52
1.54
0.59
2.6
1.6
—
—
—
0
0
0
22
0.00
0.59
0.0
2.5
—
—
—
0
0
0
22
0.00
0.59
0.0
2.5
—
—
—
0
0
8
54
1.49
0.57
1.1
1.2
—
—
—
0
0
18
132
1.37
0.57
1.2
1.2
—
—
—
0
0
8
55
1.46
0.56
1.1
1.2
—
—
—
0
0
6
37
1.63
0.55
1.7
1.6
—
—
—
0
0
111
999
1.13
0.54
4.5
4.5
2.63
2.26
ug/l
0.27
98
888
797
7833
1.10
0.53
3.9
3.8
1.23
1.27
mmol/l
0.87
733
7208
6
39
1.54
0.53
1.5
2.3
—
—
—
0
0
116
1049
1.12
0.52
3.2
1.9
30.51
29.51
s
0.50
110
1017
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
23
179
1.29
0.51
4.8
2.7
0.34
0.35
u/ml
—
8
98
10
144
0.69
0.49
1.0
1.5
—
—
—
0
0
89
796
1.13
0.49
3.6
4.0
21.39
21.78
%
0.10
34
363
178
1655
1.09
0.48
1.6
1.7
78710099.55
34540619.30
pmol/l
0.36
155
1381
13
94
1.39
0.46
1.0
1.1
—
—
—
0
0
7
49
1.43
0.46
2.4
2.1
—
—
—
0
0
7
50
1.40
0.45
1.4
1.2
—
—
—
0
0
19
149
1.28
0.42
2.1
2.0
131.57
129.41
g/l
0.15
14
111
26
213
1.23
0.41
1.1
1.1
—
—
—
0
0
28
232
1.21
0.40
1.3
1.4
—
—
—
0
0
28
232
1.21
0.40
1.3
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
100
915
1.10
0.39
1.4
1.8
1.37
1.39
%
0.06
87
813
33
279
1.19
0.39
1.3
1.5
—
—
—
0
0
28
233
1.21
0.39
1.3
1.4
—
—
—
0
0
28
233
1.21
0.39
1.3
1.4
—
—
—
0
0
27
224
1.21
0.38
4.0
1.9
94.70
93.59
%
0.10
27
214
5
36
1.39
0.38
1.2
1.6
—
—
—
0
0
9
67
1.35
0.38
1.7
1.6
—
—
—
0
0
9
67
1.35
0.38
1.7
1.6
—
—
—
0
0
9
67
1.35
0.38
1.7
1.6
—
—
—
0
0
76
687
1.12
0.37
2.4
2.0
0.21
0.22
g/l
0.13
68
647
23
189
1.22
0.36
2.2
4.0
15.70
33.79
u/ml
1.87
23
184
87
948
0.91
0.34
6.7
6.2
—
—
—
0
0
26
218
1.20
0.34
1.4
1.3
—
—
—
0
0
6
45
1.34
0.33
1.0
1.3
—
—
—
0
0
21
173
1.22
0.33
1.9
1.5
—
—
—
0
0
35
401
0.87
0.32
1.7
1.5
—
—
—
0
0
13
101
1.29
0.32
2.2
1.4
—
—
—
0
0
11
84
1.31
0.30
2.5
1.5
—
—
—
0
0
11
84
1.31
0.30
2.5
1.5
—
—
—
0
0
68
740
0.91
0.28
2.8
4.2
10.99
21.92
ug/l
0.58
53
592
96
896
1.08
0.27
2.0
1.9
—
—
—
0
0
23
268
0.85
0.27
1.1
1.4
74.17
213.49
pmol/l
1.45
23
262
13
160
0.81
0.26
4.0
3.7
34.67
23.88
mg/l
—
6
99
86
803
1.08
0.25
1.9
1.8
—
—
—
0
0
5
38
1.32
0.23
1.4
2.2
—
447.80
—
0
5
5
38
1.32
0.23
3.2
2.7
67180.00
36608.03
ug/l
—
5
38
44
400
1.10
0.22
1.3
1.4
—
—
—
0
0
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
31
346
0.89
0.21
1.6
1.7
2.90
4.78
mg/l
0.52
22
248
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
6
48
1.25
0.20
1.0
1.1
—
—
—
0
0
6
49
1.23
0.20
1.2
1.2
—
—
—
0
0
6
49
1.23
0.20
1.5
1.5
1.73
1.62
g/l
—
6
49
7
62
1.13
0.17
3.1
2.5
—
—
—
0
0
15
173
0.86
0.17
1.1
1.5
—
—
—
0
0
53
496
1.07
0.16
2.8
2.8
5.11
4.60
kpa
1.17
48
483
19
168
1.13
0.15
1.9
1.5
—
—
—
0
0
6
78
0.77
0.15
2.7
1.4
—
—
—
0
0
43
403
1.07
0.13
1.3
1.5
—
—
—
0
0
308
3032
1.02
0.11
3.7
3.5
—
—
—
0
0
10
114
0.88
0.09
2.7
1.7
53.60
43.98
nmol/l
—
10
108
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
47
1.06
0.09
1.0
1.2
—
—
—
0
0
21
194
1.08
0.09
1.4
1.4
—
—
—
0
0
6
55
1.09
0.09
1.2
1.1
—
—
—
0
0
6
57
1.05
0.08
1.5
1.6
0.91
1.02
g/l
—
6
57
8
77
1.04
0.07
1.9
1.8
154.25
214.06
pmol/l
—
8
71
204
2069
0.98
0.07
3.8
3.8
0.00
0.00
estimate
1.08
87
718
10
89
1.12
0.07
1.2
1.1
—
—
—
0
0
9
103
0.87
0.06
1.0
1.1
—
—
—
0
0
58
562
1.03
0.06
7.7
6.6
8.56
8.79
mmol/l
0.11
50
539
16
171
0.93
0.05
1.8
2.2
10.75
131.92
ug/min
2.14
11
100
43
416
1.04
0.05
3.2
3.3
1.84
1.80
mmol/l
0.02
33
316
31
323
0.96
0.05
2.9
3.3
24.95
25.51
mmol/l
0.46
25
314
14
150
0.93
0.04
1.1
1.2
—
—
—
0
0
10
109
0.92
0.04
1.0
1.4
—
—
—
0
0
10
109
0.92
0.04
1.5
1.5
—
—
—
0
0
57
557
1.02
0.04
2.1
2.3
6.19
6.25
ug/l
0.01
47
492
15
141
1.06
0.03
3.6
3.7
161.16
2517.33
u/ml
0.74
15
135
86
847
1.02
0.03
7.1
6.1
104.59
104.22
mmol/l
0.32
86
847
10
92
1.09
0.03
2.2
1.5
—
—
—
0
0
10
108
0.93
0.03
1.0
1.4
—
—
—
0
0
13
122
1.07
0.02
2.2
1.8
—
—
—
0
0
21
202
1.04
0.02
1.8
1.5
—
—
—
0
0
10
107
0.93
0.02
1.0
1.4
—
—
—
0
0
32
312
1.03
0.02
1.5
2.1
213.50
4089.21
u/l
—
10
127
13
123
1.06
0.01
1.1
1.1
—
—
—
0
0
42
412
1.02
0.01
3.2
3.0
133.05
128.40
g/l
0.69
37
401
169
1680
1.01
0.01
3.3
3.8
1.02
1.02
kg/l
0.32
24
241
10
106
0.94
0.01
1.0
1.1
—
—
—
0
0
10
106
0.94
0.01
1.0
1.4
—
—
—
0
0
10
106
0.94
0.01
1.0
1.4
—
—
—
0
0
14
146
0.96
0.00
2.1
1.3
—
—
—
0
0
12
122
0.98
0.00
2.0
1.5
—
—
—
0
0
100
996
1.00
0.00
4.7
4.3
33.72
32.61
%
0.43
71
674
14
137
1.02
0.00
1.2
1.2
281.38
241.87
u/ml
—
8
80
13
127
1.02
0.00
2.1
1.5
—
—
—
0
0
17
173
0.98
0.00
1.1
1.4
—
—
—
0
0
18
181
0.99
0.00
1.4
1.6
624.50
165.03
e6/l
0.34
12
144
18
181
0.99
0.00
1.4
1.5
10.27
14.26
e6/l
0.14
11
140
12
121
0.99
0.00
1.3
1.2
14.35
18.60
u/l
0.37
12
103
75
745
1.01
0.00
3.0
2.9
—
—
—
0
0
18
185
0.97
0.00
1.1
1.2
—
—
—
0
0
10
105
0.95
0.00
1.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
6
63
0.95
-0.00
3.5
1.5
18.67
18.17
ug/l
—
6
63
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
6.54
—
0
7
0
9
0.00
-0.00
0.0
8.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.04
—
0
6
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
43
430
1.00
-0.00
1.4
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
70
1.00
-0.00
1.3
1.0
—
—
—
0
0
9
97
0.93
-0.00
1.4
1.5
—
—
—
0
0
5
59
0.85
-0.00
1.6
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
79
1.01
-0.00
1.4
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: H7_LACRIMALORBITINOTH – Disorders of lacrimal system and orbit in diseases classified elsewhere
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).